An advocacy group for patients with anaplastic lymphoma kinase positive lung cancer has awarded a $500,000 grant dedicated to overcoming treatment resistance to the cancer.
Two researchers from Vanderbilt-Ingram Cancer Center (VICC) are featured in Clinical Cancer Advances 2020: ASCO’s Annual Report on Progress Against Cancer.
Rhea Dodd is the first patient treated with an experimental cancer vaccine derived from a completely new cell engineering platform.
Ben Ho Park, MD, PhD, has been named interim director of the Division of Hematology and Oncology.
Vanderbilt-Ingram Cancer Center’s Justin Balko, PharmD, PhD, has received a $100,000 research grant from the Mary Kay Foundation.
The identification of a protein important for insulin synthesis may hold clues for understanding the pathogenesis of diabetes.